Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

Moisés Calderon 1 Pascal Demoly 2, 3 Thomas Casale 4 Cezmi Akdis 5 Claus Bachert 6 Michael Bewick 7 Maria Beatrice Bilò 8 Barbara Bohle 9 Sergio Bonini 10, 11 A Bush 1 Davide Caimmi 2, 3 Giorgio Walter Canonica 12 Victoria Cardona 13 Anca Mirela Chiriac 2, 3 Linda Cox 14 Adnan Custovic 1 Frédéric De Blay 15 Philippe Devillier 16 Alain Didier 17 Gabriele Di Lorenzo 18, 19, 20 George Du Toit 19 Stephen Durham 1 Peter Eng 21 Alessandro Fiocchi 22 A. T. Fox 19 Roy Gerth van Wijk 23 R. M. Gomez 24 Tari Haathela 25 Susanne Halken 26 Peter Hellings 27 Lars Jacobsen 28 Jocelyne Just 2, 29 Luciana Tanno 2, 30, 31 J. Kleine-Tebbe 32 Ludger Klimek 33 Edward Knol 34 Piotr Kuna 35 Désirée Larenas-Linnemann 36, 37 Allan Linneberg 38, 39, 40 M. Matricardi 41 Hans-Joergen Malling 42 Ralph Moesges 43 Joaquim Mullol 44 Antonella Muraro 45 Nikos Papadopoulos Giovanni Passalacqua 46 Elideanna Pastorello 47 Olivier Pfaar 48, 49, 50 David Price 51, 52, 53 Pablo Rodriguez del Rio 54 R. Ruëff 55 Boleslaw Samolinski 56 Glenis Scadding 57, 58 Gabriela Senti 59 Mohamed Shamji 1, 60 Aziz Sheikh 61 Juan Carlos Sisul 62 Dirceu Sole 63 Gunter Sturm 64, 65 Ana Tabar 66 Ronald Van Ree 67 Maria Teresa Ventura 68 Carmen Vidal 69 Eva Maria Varga 64 Margitta Worm 70 Torsten Zuberbier 70 Jean Bousquet 71, 72, *
* Auteur correspondant
Abstract : Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
Type de document :
Article dans une revue
Clinical and Translational Allergy, BioMed Central, 2016, 6 (1), pp.41. 〈10.1186/s13601-016-0131-x〉
Liste complète des métadonnées

Littérature citée [129 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01401204
Contributeur : Bmc Bmc <>
Soumis le : mercredi 23 novembre 2016 - 08:03:09
Dernière modification le : mardi 15 mai 2018 - 01:20:39
Document(s) archivé(s) le : mardi 21 mars 2017 - 10:20:53

Fichier

13601_2016_Article_131.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Citation

Moisés Calderon, Pascal Demoly, Thomas Casale, Cezmi Akdis, Claus Bachert, et al.. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clinical and Translational Allergy, BioMed Central, 2016, 6 (1), pp.41. 〈10.1186/s13601-016-0131-x〉. 〈inserm-01401204〉

Partager

Métriques

Consultations de la notice

128

Téléchargements de fichiers

124